{"output": [["Enanta Pharmaceuticals Inc.", "COMP", "Provide Updates", "Business Outlook", "CONCEPT"], ["Enanta Pharmaceuticals Inc.", "COMP", "Initiate", "Phase 1 Clinical Study", "EVENT", "Of", "Edp-938", "PRODUCT", "For", "Respiratory Syncytial Virus", "CONCEPT"], ["Enanta Pharmaceuticals Inc.", "COMP", "Initiate", "Phase 2 Clinical Study", "EVENT", "\"Intrepid\"", "Of", "Edp-305", "PRODUCT", "In", "Patients", "PERSON", "With", "Primary Biliary Cholangitis", "CONCEPT"], ["Enanta Pharmaceuticals Inc.", "COMP", "Support", "Advancing", "VERB", "Research", "CONCEPT", "And", "Development", "CONCEPT", "Programs", "CONCEPT", "With", "Strong Cash Balance", "CONCEPT", "Of", "$294M", "ECON_INDICATOR", "As", "Of", "Sep", "GPE", "30", ",", "2017", "TIME"]], "published": "2018-01-05T14:33:00.000+02:00"}